nps-568 has been researched along with Vasospasm, Intracranial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eren, B; Güleç, İ; Karacan, M; Karagöz-Güzey, F; Önay-Uçar, E; Özcan, TB; Şengelen, A; Vahabova, G | 1 |
1 other study(ies) available for nps-568 and Vasospasm, Intracranial
| Article | Year |
|---|---|
The calcimimetic R-568 attenuates subarachnoid hemorrhage-induced vasospasm through PI3K/Akt/eNOS signaling pathway in the rat model.
Topics: Animals; Calcimimetic Agents; Disease Models, Animal; Male; Nitric Oxide Synthase Type III; Phenethylamines; Phosphatidylinositol 3-Kinases; Propylamines; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2021 |